Charles River Laboratories International, Inc.
NYSE · Healthcare · Services-Commercial Physical & Biological Research · Wilmington, MA
CRL chart
What traders are saying about $CRL
Latest postsCharles River Laboratories International, Inc. news
- Charles River Laboratories International (CRL) Contributed to Madison Small Cap Fund’s Healthcare Outperformance
Yahoo Finance ·
- Charles River Leverages Virtual Control Groups in GLP Studies
Yahoo Finance ·
- An approach could cut animal use by up to 12%; Charles River will supply data for an Ipsen study.
Stock Titan ·
- Charles River Laboratories International, Inc. (NYSE:CRL) Rises 3.45%
Kalkine India ·
- Form 4 Charles River Laboratories International, Inc: James C. Foster (Director) For: 22 October
Investing.com Canada ·
- A Look at Charles River Laboratories International Inc (CRL) Aft
GuruFocus ·
- After exercising options, Charles River (CRL) director Foster sells 24,042 shares at $350.
Stock Titan ·
- Charles River Laboratories’ Q3 2026 Earnings: What to Expect
barchart.com ·
- Charles River Laboratories International (CRL) Has Fresh Attention, But What Is Behind It?
Simply Wall Street ·
- Does FDA Drug Testing Partnership Change The Bull Case For Charles River Labs Stock?
Simply Wall Street ·
- Charles River Laboratories International, Inc. (CRL) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Charles River Laboratories International Inc. stock outperforms competitors on strong trading day
MarketWatch ·
Charles River Laboratories International, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $4.02B | $4.05B | $4.13B | $3.98B |
| Net income | -$144.3M | $22.2M | $474.6M | $486.2M |
| Diluted EPS | $-2.91 | $0.20 | $9.22 | $9.48 |
| Total assets (year end) | $7.14B | $7.53B | $8.20B | $7.60B |
| Cash and equivalents (year end) | $213.8M | $194.6M | $276.8M | $233.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Charles River Laboratories International, Inc.
- Ticker
- CRL (NYSE)
- Industry
- Services-Commercial Physical & Biological Research
- Headquarters
- Wilmington, MA
- Fiscal year end
- December 27
- SEC CIK
- 1100682
- Former names
- CHARLES RIVER LABORATORIES INTERNATIONAL INC, CHARLES RIVER LABORATORIES HOLDINGS INC
Frequently asked questions
What exchange is Charles River Laboratories International, Inc. listed on?
Charles River Laboratories International, Inc. trades on the NYSE under the ticker symbol CRL.
What industry is Charles River Laboratories International, Inc. in?
Charles River Laboratories International, Inc. is classified by the SEC under "Services-Commercial Physical & Biological Research", part of the Healthcare sector on StockTweeting.
Where is Charles River Laboratories International, Inc. headquartered?
Charles River Laboratories International, Inc.'s business address on file with the SEC is in Wilmington, MA.
When does Charles River Laboratories International, Inc.'s fiscal year end?
Charles River Laboratories International, Inc.'s fiscal year ends on December 27.
How much revenue did Charles River Laboratories International, Inc. report?
Charles River Laboratories International, Inc. reported $4.02B in revenue for calendar year 2025, according to its SEC filings.